Rodney E. Marcy

Interlace Medical, Inc. develops gynecological devices. The company was founded by Bill Gruber in 2006 and is headquartered in Marlborough, MA.

Halt Medical, Inc. operates as a medical device company which focuses on manufacturing symptomatic uterine fibroids. It has developed and launched the Acessa procedure which utilizes a technology called radiofrequency ablation, and treats each fibroid by applying energy through a small needle array. The company was founded by Ed Calesa, Bruce B. Lee and Jeffrey M. Cohen in 2004 and is headquartered in Brentwood, CA.

Part of Sanarus Technologies LLC, Sanarus Medical, Inc. manufactures minimally invasive medical devices. The company is based in Pleasanton, CA. The company was founded in 1999 by Seth A. Stabinsky, Glenn Foy. The CEO is BJ Hardman. Sanarus Medical was acquired by Sanarus Technologies LLC on July 16, 2009.

Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ.

Covidien LP manufactures and distributes medical devices. Its products include disposable medical supplies, monitoring equipment, innovative wound closure products, advanced surgical devices, medical instruments and bulk analgesic pharmaceuticals. The company is headquartered in Mansfield, MA.

Gynecare, Inc. designs medical devices for the treatment of uterine problems. The company was founded on March 8, 1994 and is headquartered in Somerville, NJ.

Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA.